
Sign up to save your podcasts
Or


Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression
By John Simboli5
77 ratings
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression

533 Listeners

3,071 Listeners

1,092 Listeners

942 Listeners

795 Listeners

125 Listeners

322 Listeners

96 Listeners

9,946 Listeners

34 Listeners

517 Listeners

146 Listeners

349 Listeners

181 Listeners

468 Listeners